凯复

Caref Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative small molecule drugs for the treatment of cancer and other life-threatening diseases. The company leverages its expertise in medicinal chemistry and structure-based drug design to develop highly selective therapies, including next-generation PARP inhibitors and endocrine therapies. Its lead programs target hormone-driven cancers and DNA damage response pathways, with several candidates currently undergoing clinical evaluation in China and the United States. Caref Pharmaceuticals aims to address unmet medical needs by providing more effective and safer treatment options for patients with advanced malignancies.